Evofem Biosciences (EVFM)
(Delayed Data from OTC)
$0.02 USD
0.00 (18.31%)
Updated Apr 26, 2024 03:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EVFM 0.02 0.00(18.31%)
Will EVFM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for EVFM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EVFM
Why Endo (ENDP) Stock Wilted After its Surge on Tuesday?
EVFM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for EVFM
Evofem Biosciences Issues Update with Latest Presentation
EVFM Stock Earnings: Evofem Biosciences Reported Results for Q4 2023
Evofem Biosciences Inc Investor Call Transcript
Q1 2022 Evofem Biosciences Inc Earnings Call Transcript
Q2 2022 Evofem Biosciences Inc Earnings Call Transcript